Observational studyMedicine2017

Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy.

Tsutomu Mizoshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.